Abstract: A compound comprising a first ligand LA of Formula I, where moiety A has a structure of Formula II, or Formula III, and G comprises a structure of Formula IV, is provided. In LA, moiety B is one or more rings; ring C is a 5- or 6-membered ring; each of Z1, Z2, Z3, and X1 to X8 is C or N; K is a direct bond or selected from the group consisting of O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA, RB, RC, and RD is hydrogen or a General Substituent; LA is coordinated to a metal M selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, and Cu; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of a first ligand LA of Formula I, is provided. In Formula I, moieties A and B are each a monocyclic ring or a polycyclic fused-ring system; Z1 to Z4 are each C or N; K is a direct bond, O, or S; each RA and RB is independently a hydrogen or a General Substituent; at least one RA or RB is R*, wherein R* has a structure of Formula II, —L—GeR1R2R3; L is a direct bond or an organic linker; and LA is coordinated to a metal M by the dashed lines; and metal M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, or Cu.

Abstract: A compound comprising a first bidentate ligand LA having a structure of Formula I, is provided. In Formula I, each of Y1 to Y12 is CR or N; each R can be same or different; each R is hydrogen or a substituent; at least one pair selected from Y3-Y4, Y7-Y8, or Y11-Y12 are CR and the Rs are joined or fused into a ring; and LA is complexed to a metal M selected from the group consisting of Os, Ir, Pd, and Pt. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a ligand LA coordinated to a metal M, the ligand LA selected from the group consisting of Formula I, Formula II, and Formula III ring A is a 5- or 6-membered carbocyclic or heterocyclic ring; wherein ring A of Formula I connects to ring B at X1, X2, or X3 to form a five-membered chelate ring with the metal; Z1 and Z2 are independently selected from C or N; and X1 to X10 are independently selected from C or N. An organic light emitting device (OLED) comprising an anode, a cathode and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from Formula I, Formula II, or Formula III, and a consumer product comprising the OLED.

Abstract: Tetradentate platinum complexes comprising an imidazole/benzimidazole carbene having a structure of Formula I is disclosed. In Formula I, M is Pd or Pt. These platinum carbenes with the specific substituents disclosed herein are novel and provides phosphorescent emissive compounds that exhibit physical properties that can be tuned, such as sublimation temperature, emission color, and device stability.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula II, wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least two adjacent ones of X1, X2, X3, and X4 are CR and fused into a five or six-membered aromatic ring R3 represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each R, R1, and R3 is independently hydrogen or a General Substituent defined herein; R2 is a General Substituent defined herein; and two substituents can be joined or fused to form a ring; the ligand LA is complexed to a metal M through the two indicated dash lines of each Formula; and the ligand LA can be joined with other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Abstract: A compound having a formula M(LA)x(LB)y(LC)z is provided. In the compound of M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is In addition, M is a metal having an atomic mass greater than 40, x is 1, 2, or 3, and y and z are independently 0, 1, or 2. In the compound, Z5 is carbon or nitrogen; one of Z1 to Z4 is nitrogen and three of Z1 to Z4 are carbon substituted by RB, and rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring. Each RA, RB, RC, and RD is independently selected from a group of substituents, where at least one RB is heteroaryl, which can be further substituted, and any adjacent substitutents are optionally joined or fused into a ring. Formulations and devices, such as OLEDs, that include the first compound are also provided.

Abstract: A compound comprising a first ligand LA having a structure of Formula I, is provided. In Formula I, L is a direct bond a specified linker; each of X1 to X4 is C or N; K is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); at least one RA or RB is R*, comprising a structure of Formula II, each of moiety A, B, and C is a monocyclic ring or a polycyclic fused ring system; n is an integer from 1 to 6; LR is a direct bond or an organic linker; each Z is CR, CRR?, SiRR?, or GeRR?; at least one Z is SiRR? or GeRR?; and LA is coordinated to a metal M selected. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A compound comprising a first ligand LA having a Formula selected from: is disclosed. In the Formulas rings B and C are 5-membered or 6-membered aromatic or heteroaromatic ring; Z1, Z2, X1, X2, X3, X4, X5, and X6 are each C or N, but X1, X2, X3, or X4 is C when it forms a direct bond to Z2; Y is selected from CRR?, NR?, O, S, and Se; R, R?, RA, RB, RC, and RD are each selected from a variety of substituents; the ligand LA is coordinated to a metal M by the dashed lines, and optionally to other ligands. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: A composition including a first compound capable of functioning as a phosphorescent emitter in an OLED is provided. The first compound has at least one aromatic ring and at least one substituent R directly bonded to one of the at least one aromatic rings. Each substituent R has the formula of where (a) G1 is selected from NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; and G2 is a non-aromatic polycyclic group; (b) G1 is a direct bond; and G2 is a non-aromatic spiro polycyclic group; or (c) G1 is selected from direct bond, NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; G2 is a non-aromatic polycyclic group; and R is directly bonded to a phenyl, pyridine, or triazine. R1, R2, and R3 are are a variety of substituents. Formulations and devices, such as an OLEDs, that include the first compound are also described.

Abstract: Provided are compounds having a formula of Ir(LA)p(LB)q(LC)r, wherein LA has a structure of Formula IA: LB has a structure of Formula IB: . Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a first ligand LA of Formula I, where at least one RA or RB comprises R of Formula II, is provided. In Formula I and II, moieties A and B are independently single rings or multicyclic ring systems; Z1 and Z2 are each C or N; L and L1 are linkers; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); y is 1, 2, or 3; each R?, R?, R?, R?, R1, R2, RA, RB, and RC is independently hydrogen or a General Substituent; and LA is complexed to a metal M to form a 5-membered or 6-membered chelate ring. Formulations, OLEDs, and consumer products including the compound are also provided.

Abstract: Provided is a compound having a formula of Ir(LA*)m(LB*)n(LC*)p; wherein each LA, LB, and LC is independently a monoanionic bidentate ligand and different from each other; n and p each is independently 0, 1, or 2; m is 1 or 2; and m+n+p is 3; a free-state of LA has a first triplet energy T1 of EA at 77K; a free-state of LB has a first triplet energy T1 of EB at 77K; a free-state of LC has a first triplet energy T1 of EC at 77K; EA is less than EB and EC whichever EB and EC is present; LA comprises at least one ?-electron deficient electron-withdrawing group; and the compound has an emission spectrum with a FWHM value of no more than 45 nm. Also provided is a compound comprising a first ligand LA having a structure of Formula I, wherein the variables are defined herein.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: A compound of Formula Ir(LA)n(LB)m(LC)p is provided where m and n are 1 or 2, p is 0 or 1, and m+n+p=3. Ligand LA has a structure of ligand LB has a structure of and ligand LC is a bidentate ligand. In the compound, ring A? is a ring or is absent; each of R1 and R1? is alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, silyl, germyl, or a combination thereof; moiety C is a monocyclic ring or a fused ring system; each of Z1 and Z2 and X1 to X11 is independently C or N, except that X12 and X13 are C if ring A? is present; each RA, RA?, RB, RC, and RD is hydrogen or one of the General Substituents; and at least one RC or RD comprises an electron withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I is provided. In Formula I, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of Z1 to Z4 is C or N; one of K1 or K2 is a direct bond, and the other is a direct bond or a linker; L is a linker; each R?, R?, R, R?, RA, and RB is a General Substituent defined herein; LA is coordinated to a metal M; and the compound includes at least a silyl group, a germyl group, or an electron-withdrawing group. Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: Provided is a compound of Formula of Ir(LA)n(LB)m(LC)o, wherein ligand LA has a structure of Formula I, ligand LB has a structure of Formula II, and LC is a bidentate ligand; and wherein n is 1, or 2; m is 1, or 2; o is 0, or 1; and n+m+o=3; and all the remaining variables are defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A heteroleptic compound of formula Ir(LA)m(LB)n(LC)p is provided wherein LA has a structure of Formula IA, or Formula IB, LB has a structure of Formula II, and LC is a bidentate ligand; and wherein m is 1 or 2; n is 1 or 2; and p is 0 or 1; and m+n+p=3In Formulae I and II, moieties A and D are heterocyclic ring or a polycyclic ring system; each of X1 to X12 is C or N; Ring B is connected to moiety A by a C; at least one of X9 to X12 is N; Y is a linking group that forms a 5-membered ring; each R, R?, R?, RA, RB, RC, RD, and RE is hydrogen or a General Substituent as defined herein; LA forms a 5-membered chelate ring with Ir. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Cyclometalated iridium complexes having triphenylene or aza triphenylene and bulky alkyl substitution that can be used as emitters in OLEDs to improve the external quantum efficiency (EQE) and lifetime of OLEDs are disclosed.